Article Text

Download PDFPDF
PTU-141 A Pragmatic Randomised Controlled Trial of Healing Therapy in a Gastroenterology Outpatient Setting
  1. R lee1,
  2. T Kingstone2,
  3. L Roberts3,
  4. S Edwards4,
  5. A Soundy5,
  6. P Shah1,
  7. MS Haque6,
  8. S Singh7
  1. 1Integrated Medicine Department, Freshwinds, Birmingham, UK., birmingham
  2. 2Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire, keele
  3. 3Warwick Medical School, University of Warwick, Coventry, coventry
  4. 4Healer Member of The Healing Trust
  5. 5Department of Physiotherapy, University of Birmingham
  6. 6Primary Care Clinical Sciences, University of Birmingham
  7. 7Good Hope Hospital, birmingham, UK


Introduction To determine benefits of healing therapy as an adjunct to conventional management in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

Methods : 200 outpatients with IBS or IBD were randomised to either conventional treatment or conventional plus 5 sessions of healing therapy. After 12 weeks Controls also had healing therapy. Outcomes used were, the Measure Yourself Medical Outcomes Profile (MYMOP). IBS-QOL and IBDQ and symptom measures.

Results There was a significant improvement in the MYMOP score at week 6 (p < 0.001) which was maintained to week 12 (p < 0.001) and 24 (p < 0.001). Improvements in MYMOP were significantly greater in the intervention group at both 6 (p < 0.001) and 12 weeks (p < 0.001) with effect sizes of 0.7 (95% CI: 0.4 to 1.1) and 0.8 (95% CI: 0.4 to 1.2). Condition specific data for IBS showed that most QoL dimensions had a significant minimum 10 point score improvement at 6 and 12 weeks. The overall score improvement was 12.9 units at week 6 (p < 0.001), 12.4 units at week 12 (p < 0.001) and 13.8 units at 24 weeks (p < 0.001). In IBD there was also similar score improvement but only up to week 12 associated with improved social (p < 0.001) and bowel (p < 0.001) functions. Between group difference identified for QoL scores in IBS at both week 6 (p < 0.001) and 12 (p < 0.001) but only for week 12 (p < 0.001) in the IBD group.

Conclusion The addition of healing therapy in IBS was associated with improvements in symptoms and QoL in IBS, and to a lesser extent in IBD.

Disclosure of Interest None Declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.